August 31, 2021
Alnylam Japan said on August 30 that its small-interfering RNA (siRNA) therapy Givlaari (givosiran) is now available in Japan for the treatment of acute hepatic porphyria (AHP). It is the second siRNA drug in the country, after the company’s Onpattro...read more